Join to View Full Profile
Erie Avenue At Front StreetSt. Christopher's Hospital, Pediatric PulmonologyPhiladelphia, PA 19134
Phone+1 215-427-5183
Fax+1 215-427-4621
Dr. Steinfeld is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jonathan Steinfeld, MD, is a Pediatric Pulmonologist based in Philadelphia, PA. He completed his medical education at MCP-Hahnemann College of Medicine in 1998, followed by a Pediatrics residency at Tower Health/St. Christopher's Hospital for Children, and a Pediatric Pulmonology fellowship at UPMC Medical Education. He has numerous publications in respiratory and eosinophilic disorders, most notably in ERJ Open Research, ACR Open Rheumatology, The Journal of Allergy and Clinical Immunology in Practice, and Frontiers in Immunology. His works primarily focus on Mepolizumab's clinical benefits and its effects on Hypereosinophilic Syndrome, EGPA, and pediatric asthma.
Education & Training
UPMC Medical EducationFellowship, Pediatric Pulmonology, 2001 - 2004
Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1998 - 2001
MCP-Hahnemann College of MedicineClass of 1998
Certifications & Licensure
PA State Medical License 2001 - 2026
NJ State Medical License Active through 2013
Publications & Presentations
PubMed
- 18 citationsMepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics.David R W Jayne, Benjamin Terrier, Bernhard Hellmich, Paneez Khoury, Lee Baylis
ERJ Open Research. 2024-01-01 - 23 citationsClinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype.Benjamin Terrier, David R W Jayne, Bernhard Hellmich, Jane H Bentley, Jonathan Steinfeld
ACR Open Rheumatology. 2023-07-01 - 17 citationsMepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.Marc E Rothenberg, Florence Roufosse, Stanislas Faguer, Gerald J Gleich, Jonathan Steinfeld
The Journal of Allergy and Clinical Immunology. in Practice. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
